{"id":"W4231537586","doi":"10.2165/00128413-200615510-00066","title":"Health Canada has approved rituximab [Rituxan; Roche] as a maintenance therapy for patients with follicular non-Hodgkin's lymphoma","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Oncology; Lymphoma; Hodgkin lymphoma; Maintenance therapy; Internal medicine; Pharmacy; Family medicine; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001084627,0.0002789182,0.0005473522,0.0007146945,0.001596525,0.0009405006,0.0009765937,0.001790368,0.01131008],"category_scores_gemma":[0.00150789,0.0002196895,0.0005922221,0.0007041989,0.0006664498,0.0002057263,0.000279719,0.001679755,0.001989297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006778314,"about_ca_system_score_gemma":0.02178132,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3317898,"about_ca_topic_score_gemma":0.6820464,"domain_scores_codex":[0.9992901,0.0001499784,0.00003195988,0.00004993218,0.0002888262,0.0001892022],"domain_scores_gemma":[0.9977747,0.0004185687,0.0001645585,0.00006202215,0.0008075729,0.0007726105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003665701,0.001108587,0.05136814,0.0008117294,0.0002562806,0.002749921,0.0002669351,0.0007076475,0.02669735,0.003401357,0.3166892,0.5922771],"study_design_scores_gemma":[0.002725673,0.003489047,0.08202838,0.0003278429,0.0004320825,0.003554027,0.0001884871,0.001114631,0.01019714,0.0003548476,0.895526,0.00006182774],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.303723,0.1068666,0.006902311,0.107316,0.005249604,0.002329593,0.008229656,0.002698202,0.4566851],"genre_scores_gemma":[0.7285475,0.0285952,0.01797551,0.03731734,0.001797209,0.0004046015,0.006911994,0.0003604037,0.1780903],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.6682102,"threshold_uncertainty_score":0.6597171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007872528325920655,"score_gpt":0.2359594050837431,"score_spread":0.2280868767578225,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}